newsfilter
← Latest News
PR Newswire·

Provention Bio Announces Senior Leadership Addition

RED BANK, N.J., Sept. 19, 2022 /PRNewswire/ -- Provention Bio, Inc. (NASDAQ:PRVB) (the "Company"), a biopharmaceutical company dedicated to intercepting and preventing immune-mediated diseases, today announced that the Company has appointed Sarah O'Brien